Literature DB >> 8977359

The renin-angiotensin system and the heart: a historical review.

S J Cleland1, J L Reid.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977359      PMCID: PMC484481          DOI: 10.1136/hrt.76.3_suppl_3.7

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  75 in total

1.  Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man.

Authors:  J H LARAGH; M ANGERS; W G KELLY; S LIEBERMAN
Journal:  JAMA       Date:  1960-09-17       Impact factor: 56.272

2.  [Aldosterone activity and sodium retention in heart disease and its pathophysiologic significance].

Authors:  E BUCHBORN; K R KOCZOREK; M KOHLER; H P WOLFF
Journal:  Klin Wochenschr       Date:  1956-11-01

3.  Cardiac and vascular actions of decapeptide angiotensin analogs.

Authors:  K M Baker; M C Khosla
Journal:  J Pharmacol Exp Ther       Date:  1986-12       Impact factor: 4.030

4.  Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung.

Authors:  Y S Bakhle
Journal:  Nature       Date:  1968-11-30       Impact factor: 49.962

5.  Essential hypertension: renin and aldosterone, heart attack and stroke.

Authors:  H R Brunner; J H Laragh; L Baer; M A Newton; F T Goodwin; L R Krakoff; R H Bard; F R Bühler
Journal:  N Engl J Med       Date:  1972-03-02       Impact factor: 91.245

6.  Radioimmunoassay determination of plasma-renin activity.

Authors:  G W Boyd; A E Fitz; A R Adamson; W S Peart
Journal:  Lancet       Date:  1969-02-01       Impact factor: 79.321

7.  Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro.

Authors:  M Campbell-Boswell; A L Robertson
Journal:  Exp Mol Pathol       Date:  1981-10       Impact factor: 3.362

8.  Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs.

Authors:  D W Cushman; F L Wang; W C Fung; C M Harvey; J M DeForrest
Journal:  Am J Hypertens       Date:  1989-04       Impact factor: 2.689

9.  Continuous inhibition of renin release in dogs by vagally innervated receptors in the cardiopulmonary region.

Authors:  G Mancia; J C Romero; J T Shepherd
Journal:  Circ Res       Date:  1975-04       Impact factor: 17.367

Review 10.  Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.

Authors:  J H Laragh
Journal:  Hypertension       Date:  1992-09       Impact factor: 10.190

View more
  5 in total

1.  Control of adipogenesis by the autocrine interplays between angiotensin 1-7/Mas receptor and angiotensin II/AT1 receptor signaling pathways.

Authors:  Aung Than; Melvin Khee-Shing Leow; Peng Chen
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

Review 2.  A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link?

Authors:  Adolfo E Cuadra; Zhiying Shan; Colin Sumners; Mohan K Raizada
Journal:  Pharmacol Ther       Date:  2009-08-31       Impact factor: 12.310

Review 3.  Angiotensinogen and the Modulation of Blood Pressure.

Authors:  Zimei Shu; Jiahui Wan; Randy J Read; Robin W Carrell; Aiwu Zhou
Journal:  Front Cardiovasc Med       Date:  2021-03-18

4.  Serum Metabolomics and Proteomics to Study the Antihypertensive Effect of Protein Extracts from Tenebrio molitor.

Authors:  Roberto Stella; Caterina Peggion; Caterina Bergantin; Giancarlo Biancotto; Maria Frosini; Elena Dreassi; Paola Marcolongo; Anna Maria Aloisi; Federica Pessina
Journal:  Nutrients       Date:  2022-08-11       Impact factor: 6.706

5.  The Prorenin and (Pro)renin Receptor: New Players in the Brain Renin-Angiotensin System?

Authors:  Wencheng Li; Hua Peng; Dale M Seth; Yumei Feng
Journal:  Int J Hypertens       Date:  2012-12-18       Impact factor: 2.420

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.